Fracture healing assessment remains a cornerstone in orthopedic care, guiding management decisions and influencing patient outcomes. Traditional imaging modalities such as radiography and computed tomography, while invaluable, are subject to interobserver variability and often lack objective quantification. Recent advances in artificial intelligence (AI) have introduced novel tools for fracture healing assessment, leveraging machine learning algorithms to enhance diagnostic accuracy, predict healing trajectories, and support clinical decision-making. This review synthesizes current scientific evidence on AI-based fracture healing assessment, discussing mechanisms, clinical applications, epidemiology, risk factors, and the integration of emerging technologies within evidence-based guidelines. The article aims to provide clinicians with a comprehensive understanding of AI-driven assessment techniques, their benefits, limitations, and future potential in musculoskeletal medicine.
Fracture healing is a complex physiological process, and accurate assessment is vital for determining treatment strategies, timing of interventions, and predicting outcomes. Traditionally, clinicians have relied on clinical evaluation supplemented by radiographic imaging to monitor healing. However, the subjective nature of these methods, coupled with subtle radiographic changes in early healing stages, poses significant challenges. In recent years, the integration of AI-driven technologies into fracture healing assessment has garnered attention, promising to improve precision, reproducibility, and early detection of complications. This article reviews the current landscape of AI-based fracture healing assessment, emphasizing its relevance for practicing clinicians and healthcare professionals engaged in musculoskeletal care.
Fractures constitute a major public health issue, with millions of cases reported worldwide each year. The incidence is particularly high among pediatric, elderly, and osteoporotic populations. Delayed union and nonunion remain significant complications, affecting up to 10% of long bone fractures and leading to substantial morbidity, prolonged disability, and increased healthcare costs. Accurate and timely assessment of fracture healing is therefore essential to reduce the burden of prolonged immobilization, surgical interventions, and associated complications. The need for objective, standardized, and efficient assessment methods has driven the development of AI-based tools in this domain.
Fracture healing involves a sequence of overlapping phases: inflammation, repair, and remodeling. The process is orchestrated by cellular and molecular events, including hematoma formation, recruitment of inflammatory cells, angiogenesis, chondrogenesis, and eventual bone remodeling. Disruptions at any stage—due to inadequate vascular supply, infection, or mechanical instability—can impair healing. Radiographically, these stages manifest as progressive callus formation, bridging of the fracture gap, and eventual restoration of bone architecture. However, radiographic findings often lag behind biological healing, underscoring the need for more sensitive and objective assessment tools.
Multiple patient-specific and injury-related factors influence fracture healing outcomes. Advanced age, comorbidities such as diabetes mellitus and osteoporosis, smoking, nutritional deficiencies, open fractures, and high-energy trauma are established risk factors for delayed healing and nonunion. Early identification and stratification of high-risk patients enable targeted interventions and close monitoring. AI algorithms, trained on large datasets, offer the potential to integrate multifactorial risk profiles and predict healing outcomes with greater accuracy than conventional methods.
Clinicians traditionally assess fracture healing through a combination of clinical and radiographic parameters. Clinical features include reduction in pain, restoration of function, and stability at the fracture site. However, subjective interpretation and variability in clinical judgment can compromise reliability. Radiographic assessment typically involves evaluation of callus formation, cortical continuity, and disappearance of the fracture line, but is limited by intra- and interobserver variability. AI-based systems have demonstrated promise in automating these assessments, reducing subjective biases, and enabling more consistent interpretation across providers.
Diagnosis of fracture healing status is crucial for determining the need for continued immobilization, surgical intervention, or rehabilitation. Traditional imaging modalities include plain radiographs, computed tomography (CT), and magnetic resonance imaging (MRI). AI-based fracture healing assessment utilizes deep learning and convolutional neural networks to analyze imaging data, extract quantitative features, and classify healing status. Several studies have validated AI models capable of distinguishing between union, delayed union, and nonunion with high sensitivity and specificity. These systems can also automate measurement of callus volume, density, and bridging, providing objective metrics to support clinical decision-making.
Management of fractures is tailored according to healing progress. Timely detection of delayed healing allows for early intervention, such as bone grafting, dynamization, or adjunctive therapies (e.g., bone stimulators). AI-driven assessment tools enable regular, automated monitoring of healing progression, facilitating personalized treatment adjustments. They can also serve as decision-support systems for selecting optimal imaging intervals, thereby reducing unnecessary radiation exposure and healthcare resource utilization.
Recent advances in AI-based fracture healing assessment encompass a wide array of technologies. Deep learning algorithms have been developed to analyze radiographs, CT, and MRI images, extracting high-dimensional features invisible to the human eye. Natural language processing (NLP) techniques allow mining of radiology reports and electronic health records for fracture-related data. Integration of multimodal data—combining clinical, imaging, and biochemical markers—enhances predictive accuracy. Emerging platforms incorporate explainable AI, enabling clinicians to interpret algorithmic predictions and build trust in automated systems. Additionally, mobile health applications and wearable sensors, powered by AI, are being explored for remote monitoring and patient engagement.
International guidelines increasingly recognize the potential of AI in musculoskeletal imaging. The American Academy of Orthopaedic Surgeons (AAOS) and European Society of Musculoskeletal Radiology (ESSR) advocate for the integration of validated AI tools as adjuncts to clinical judgment, emphasizing the need for robust validation and clinician oversight. Implementation should prioritize transparency, data security, and ethical considerations. Ongoing multicenter studies and registries are expected to inform future recommendations and facilitate widespread adoption of AI-based assessment in routine practice.
AI-based fracture healing assessment represents a transformative advancement in orthopedic practice, offering objective, reproducible, and clinically meaningful evaluations of bone healing. While challenges remain, including the need for large prospective validation studies and integration into existing workflows, current evidence supports the utility of AI as an adjunct to clinician expertise. As technology evolves, AI-driven assessment tools are poised to enhance patient care, streamline clinical workflows, and ultimately improve outcomes in fracture management.
1.
New clinical recommendation for local treatment of oligometastatic lung cancer.
2.
Charles III, King of Kings, is Cancerous.
3.
Surgery may not be necessary to treat invasive breast cancer
4.
Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.
5.
Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?
1.
Screening for Early Changes in Blood-Cell Production Capacity in Older Adults
2.
Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer
3.
Don't Ignore Your Vision Loss: What You Need to Know About Amaurosis Fugax
4.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
5.
Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
2.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
3.
How Platelet Disorders Can Affect the Body
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation